Free Trial
→ Healthcare Takes A Big Step Forward With The Help of A.I. (From Wall Street Star) (Ad) Free HRTS Stock Alerts

Tema Cardiovascular and Metabolics ETF (HRTS) Dividend Yield, Date & History

$29.83 -0.67 (-2.20%)
(As of 02:32 PM ET)
Compare

Tema Cardiovascular and Metabolics ETF Dividend Summary

Dividend Yield
1.54%
Annual Dividend
$0.46
Recent
Dividend Payment
Dec. 12

Tema Cardiovascular and Metabolics ETF (HRTS) pays an annual dividend of $0.46 per share, with a dividend yield of 1.54%. The next annual payment of $0.4693 per share was paid on Thursday, December 12, to investors who owned the stock before the ex-dividend date of Wednesday, December 11.

Get Dividend Stock Ideas Daily

Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news.

Sign Up
Skip Charts & View Dividend History

HRTS Dividend Payments by Quarter

The chart below displays up to four years of Tema Cardiovascular and Metabolics ETF's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.

HRTS Dividend Yield Over Time

The chart below tracks Tema Cardiovascular and Metabolics ETF's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.

Tema Cardiovascular and Metabolics ETF vs. The Competition

Compare Tema Cardiovascular and Metabolics ETF's annual dividend, yield, and 3-year growth rate with averages for and NASDAQ companies to evaluate its performance against the market.

TypeTema Cardiovascular and Metabolics ETF CompaniesNASDAQ Companies
Annual Dividend$0.46$0.01$1.31
Dividend Yield1.54%15.23%4.06%
Annualized 3-Year Dividend Growth0.00%33.61%14.22%

Tema Cardiovascular and Metabolics ETF Dividend History by Quarter

AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date
12/10/2024$0.4693 - 12/11/202412/11/202412/12/2024

This table shows Tema Cardiovascular and Metabolics ETF's annualdividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time.

Tema Cardiovascular and Metabolics ETF Dividend - Frequently Asked Questions

The current dividend yield for Tema Cardiovascular and Metabolics ETF is 1.54%. Learn more on HRTS's dividend yield history.

The annual dividend for HRTS shares is $0.46. Learn more on HRTS's annual dividend history.

Tema Cardiovascular and Metabolics ETF pays annual dividends to shareholders.

Related Companies
Dividend Tools
Stock Lists
Latest Articles

This page (NASDAQ:HRTS) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners
This drone stock is setting up to transform medical supply delivery
Drone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.
The Tomorrow Investor | Sponsored
Healthcare Takes A Big Step Forward With The Help of A.I.
To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...
Wall Street Star | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
Uncover the Top Gold Stock of the Bull Market
Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?
Huge Alerts | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...
Crypto Swap Profits | Sponsored
FREE Book That Could Make You a Millionaire
[FREE BOOK] Can You Make a Fortune in Crypto with $50? Get started now before the market takes off!
Crypto 101 Media | Sponsored
Do this Before Elon’s Reveal on January 22nd
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...
Brownstone Research | Sponsored
Seeing is believing…
Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...
Porter & Company | Sponsored